Perform Another (Advanced) Search

1.  Study Posting (1570) Trial #156497, Thrombosis, Morristown, NJ
...Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism The purpose of this study is to evaluate the effects of an investigational blood thinner ...
...venous thromboembolic (VTE) recurrence or death in patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) Patient Inclusion Criteria: • Men and Women greater than or equal to 18 years of ...
View Page

2.  Newly Approved Drug Therapies (259) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer,
...for use in the prevention of deep vein thrombosis (DVT) which may lead to pulmonary embolism (blood clots in the lung) in patients undergoing abdominal surgery who are at risk for ...
...factors such as a malignant tumor or a history of deep vein thrombosis or pulmonary embolism. A new indication for Lovenox was approved in March of 1998. This indication is for ...
View Page

3.  Study Posting (3716) Trial #136152, Atrial Fibrillation, Waterbury, CT
...Parallel-Arm Study to Evaluate Efficacy and Safety of Apixaban In Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation 40 month study with frequent visits within the first ...
...Parallel-Arm Study to Evaluate Efficacy and Safety of Apixaban In Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation Atrial Fibrillation Waterbury, CT 136152 Clinical Trial Participation If ...
View Page

4.  CenterWatch: Clinical Trials in Category (147) Thrombosis
...Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Morristown : Atlantic Health System Study of Apixaban for the Prevention of Thrombosis-Related Events in ...
View Page

5.  Study Posting (5193) Trial #155652, Atrial Fibrillation, Houston, TX
...to determine if apixaban is noninferior to warfarin in the endpoint of stroke and systemic embolism in individuals with AF Patient Inclusion Criteria: Must be at least 18 years of age ...
View Page

6.  Newly Approved Drug Therapies (639) Innohep (tinzaparin sodium) injectable, DuPont Merck Pharmaceutical Company,
...Company Approval Status: Approved July 2000 Treatment Area: Deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium General Information Innohep (tinzaparin sodium) injectable formulation is indicated for the treatment of acute symptomatic deep vein thrombosis, with or without pulmonary embolism when administered in conjunction with warfarin sodium. It is available in a multiple dose 2mL ...
View Page

7.  Newly Approved Drug Therapies (535) Fragmin, Pharmacia & Upjohn,
...Injection is indicated for prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism: • In patients undergoing hip replacement surgery • In patients undergoing abdominal surgery who are at risk ...
...additional risk factors such as malignancy, or a history of deep venous thrombosis or pulmonary embolism. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by Piehead ...
View Page

8.  Study Posting (713) Trial #156537, Thrombosis, Charlottesville, VA
...malignancy and a newly diagnosed, symptomatic proximal deep-vein thrombosis of the lower extremity, pulmonary embolism, or both, for research study. Deep-vein thrombosis occurs when a blood clot forms in a vein buried deep within muscle tissue. A pulmonary embolism is a blood clot that blocks an artery delivering blood to the lungs and is ...
View Page

9.  Study Posting (4561) Trial #113411, Atrial Fibrillation, Oviedo, FL
...Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation Expected Total Enrollment: 15,000 subjects worldwide Study Start ...
View Page

10.  Study Posting (713) Trial #150276, Blood Clots, Charlottesville, VA
...who have experienced a blood clot (also known as a deep vein thrombosis or pulmonary embolism) in the past 12 months and are currently taking blood thinner medications (anticoagulants) for a ...
View Page

11.  Study Posting (1570) Trial #156500, Thrombosis, Morristown, NJ
...apixaban can prevent blood clots in the leg (deep vein thrombosis [DVT]) and lung (pulmonary embolism [PE]) that sometimes occur within patients hospitalized for acute medical illness, and to learn how ...
View Page

12.  Newly Approved Drug Therapies (551) Lovenox (enoxaparin sodium) Injection, Rhone Poulenc Rorer,
...following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 ...
View Page

13.  CenterWatch: New Medical Therapies in Disease Category (147), Thrombosis
...daily. The primary efficacy outcome, a composite of symptomatic or asymptomatic deep vein thrombosis, pulmonary embolism, and death by any cause, was not reached. The rate of the primary efficacy endpoint ...
...statistically significant difference between the two treatment groups in the incidence of bleeding events, pulmonary embolism or death. This phase III, randomized, double-blind, double-dummy, international trial involved 2,303 ...
View Page

14.  Newly Approved Drug Therapies (275) Normiflo, Wyeth,
...includes DVT, the formation of blood clots following surgery and its complications such as pulmonary embolism, which can be sudden and fatal. Clinical Results In one study, dosing regimens of Normiflo ...
View Page

15.  Study Posting (2917) Trial #154937, Colon Cancer, Beech Grove, IN
...systemic anticancer therapy for treatment of metastatic colorectal carcinoma • Clinically significant cardiac disease • Recent pulmonary embolism, deep vein thrombosis, or other significant venous event Cathy Spears, Research Manager St. Francis Hospital ...
View Page

16.  Study Posting (1570) Trial #156483, Atrial Fibrillation, Morristown, NJ
...VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension requiring drug treatment, moderately ...
View Page

17.  Study Posting (2917) Trial #154938, Renal Cell Carcinoma, Beech Grove, IN
...to enrolment, and have no requirement for steroids or enzyme-inducing anticonvulsants) • History of pulmonary embolism or untreated deep venous thrombosis (DVT) within the past 6 months (unless had recent DVT ...
View Page

18.  CenterWatch: New Medical Therapies in Disease Category (316), Knee Replacement
...daily. The primary efficacy outcome, a composite of symptomatic or asymptomatic deep vein thrombosis, pulmonary embolism, and death by any cause, was not reached. The rate of the primary efficacy endpoint ...
...a low-molecular-weight heparin for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). Data showed Exanta significantly reduced the risk of proximal DVT and PE by 6 ...
View Page

19.  Newly Approved Drug Therapies (748) Arixtra, Organon, Sanofi-Synthelabo,
...away and travel through the veins to the lungs, leading to a life threatening pulmonary embolism. Clinical Results International randomized, double-blind phase III trials evaluated the use of Arixtra in ...
View Page

20.  Study Posting (5479) Trial #162088, Atrial Fibrillation, Wauwatosa, WI
...VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or systemic embolism and/or at least two of the following risk factors: hypertension requiring drug treatment, moderately ...
View Page